Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Aug 31, 2016
Insider Transaction Report
Form 4
BULLOCK DONALD R
Executive V.P. Sales
Transactions
- Disposition to Issuer
Stock Option to Buy
2016-08-29$1.59/sh−3,546$5,638→ 0 totalExercise: $20.16Exp: 2024-02-18→ Common Stock (3,546 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$10.15/sh−5,103$51,795→ 0 totalExercise: $11.60Exp: 2020-12-02→ Common Stock (5,103 underlying) - Disposition to Issuer
Common Stock
2016-08-29$21.75/sh−8,073$175,588→ 0 total - Disposition to Issuer
Stock Option to Buy
2016-08-29$6.73/sh−10,608$71,392→ 0 totalExercise: $15.02Exp: 2026-06-27→ Common Stock (10,608 underlying) - Disposition from Tender
Common Stock
2016-08-29$21.75/sh−2,583$56,180→ 8,073 total - Disposition to Issuer
Stock Option to Buy
2016-08-29$19.24/sh−607$11,679→ 0 totalExercise: $2.51Exp: 2017-08-10→ Common Stock (607 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$7.14/sh−6,522$46,567→ 0 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (6,522 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$5.30/sh−9,969$52,836→ 0 totalExercise: $16.45Exp: 2023-02-21→ Common Stock (9,969 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$17.44/sh−5,103$88,996→ 0 totalExercise: $4.31Exp: 2019-12-11→ Common Stock (5,103 underlying) - Disposition to Issuer
Stock Option to Buy
2016-08-29$17.52/sh−6,870$120,362→ 0 totalExercise: $4.23Exp: 2018-08-15→ Common Stock (6,870 underlying)
Footnotes (10)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Nichi-Iko Pharmaceutical Co. Ltd., Shepard Vision, Inc. and Sagent Pharmaceuticals, Inc. (the "Merger Agreement"), these shares were disposed of in a cash tender offer by Shepard Vision, Inc. to acquire common stock of Sagent Pharmaceuticals, Inc. in exchange for $21.75 per share in cash, without interest, less any applicable withholding taxes (the "Consideration").
- [F10]Represents the disposition of options, which provided for vesting in four equal installments beginning August 10, 2008. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $19.24 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F2]Pursuant to the Merger Agreement, these restricted shares were canceled and converted into the right to receive the Consideration.
- [F3]Represents the disposition of options, which provided for vesting in four equal installments beginning June 27, 2017. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $6.73 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F4]Represents the disposition of options, which provided for vesting in four equal installments beginning February 22, 2017. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $7.14 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F5]Represents the disposition of options, which provided for vesting in four equal installments beginning February 18, 2015. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $1.59 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F6]Represents the disposition of options, which provided for vesting in four equal installments beginning February 21, 2014. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $5.30 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F7]Represents the disposition of options, which provided for vesting in four equal installments beginning December 2, 2011. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $10.15 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F8]Represents the disposition of options, which provided for vesting in four equal installments beginning December 11, 2010. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $17.44 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.
- [F9]Represents fully vested performance options. The options were cancelled pursuant to the Merger Agreement in exchange for a cash payment of $17.52 per share subject to the option. This per share price represents the difference between the applicable exercise price of the option and the Consideration.